Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteoporosis: Spotlight on current approaches to pharmacological treatment. | Turk J Phys Med Rehabil | 2023 | 37671373 | PubTator, text mining | PubMed |
| LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature. | Arch Osteoporos | 2023 | 37659026 | PubTator, text mining | PubMed |
| β-catenin inhibitors in cancer therapeutics: intricacies and way forward. | Bioengineered | 2023 | 37655825 | PubTator, text mining | PubMed |
| Mechanism of miRNA-31 Regulating Wnt/β-catenin Signaling Pathway by Targeting Satb2 in the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells. | J Musculoskelet Neuronal Interact | 2023 | 37654220 | PubTator, text mining | PubMed |
| Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites. | Inflammopharmacology | 2023 | 37646896 | PubTator, text mining | PubMed |
| Research progress on the role of lncRNA-miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis. | Front Endocrinol (Lausanne) | 2023 | 37645421 | PubTator, text mining | PubMed |
| Systemic gene therapy rescues retinal dysfunction and hearing loss in a model of Norrie disease. | EMBO Mol Med | 2023 | 37642150 | PubTator, text mining | PubMed |
| New mutation in the β1 propeller domain of LRP4 responsible for congenital myasthenic syndrome associated with Cenani-Lenz syndrome. | Sci Rep | 2023 | 37640745 | PubTator, text mining | PubMed |
| Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms. | Front Pharmacol | 2023 | 37637408 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| Arbuscular Mycorrhizae Alter Photosynthetic Responses to Drought in Seedlings of Artemisia tridentata. | Plants (Basel) | 2023 | 37631200 | PubTator, text mining | PubMed |
| Histone Modification of Colorectal Cancer by Natural Products. | Pharmaceuticals (Basel) | 2023 | 37631010 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways. | Int J Mol Sci | 2023 | 37629148 | PubTator, text mining | PubMed |
| Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum. | Genes (Basel) | 2023 | 37628703 | PubTator, text mining | PubMed |
| LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma. | Genes (Basel) | 2023 | 37628576 | PubTator, text mining | PubMed |
| A novel pathogenic frameshift variant in AXIN2 in a man with polyposis and hypodontia. | Hered Cancer Clin Pract | 2023 | 37626374 | PubTator, text mining | PubMed |
| Maintenance of adult stem cells from human minor salivary glands via the Wnt signaling pathway. | Stem Cell Res Ther | 2023 | 37620905 | PubTator, text mining | PubMed |
Dynamics of Skeletal Status under Optimized Management during Subsequent Pregnancy in Three Women with a History of Pregnancy- and Lactation-Associated Osteoporosis Carrying pathogenic Variants in WNT1 and LRP5. | JBMR Plus | 2023 | 37614308 | PubTator, text mining | PubMed |
| Increased Bone Formation and Accelerated Bone Mass Accrual in a Man Presenting with Diffuse Osteosclerosis/High Bone Mass Phenotype and Adenocarcinoma of Unknown Primary. | JBMR Plus | 2023 | 37614304 | PubTator, text mining | PubMed |
| Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5. | Bone Res | 2023 | 37612291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=16